DOGE vowed to make government more ‘efficient’ — but it’s doing the opposite
(washingtonpost.com)
< Newsjones home
Tag: "Biotech"
The Biotech Edge: How Executives and Well-Connected Investors Make Exquisitely Timed Trades in Health Care Stocks
(propublica.org)
The FDA approved a controversial, $56,000-a-year Alzheimer's drug despite opposition inside the agency, internal memos show
CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech
